ImmunoScape vs LTZ Therapeutics
ImmunoScape vs LTZ Therapeutics, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: ImmunoScape is on 58/100 and LTZ Therapeutics on 49/100.
Where each one leads
ImmunoScape
- our overall score: 58/100 against 49/100
- domain rating: 28/100 against 4/100
LTZ Therapeutics
- agent readiness: 50/100 against 39/100
- funding raised: $76.0M against $49.7M
At a glance
| Measure | ImmunoScape | LTZ Therapeutics |
|---|---|---|
| What it is | Developing novel immunotherapies and diagnostics for cancer. | Immunotherapy company targeting oncology and autoimmune diseases. |
| Category | Biotechnology, Cancer, Immunotherapy, Diagnostics | Biotechnology, Pharmaceuticals, HealthTech, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2017 | 2021 |
| Headquarters | Singapore, Singapore | Redwood City, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | ImmunoScape | LTZ Therapeutics |
|---|---|---|
| Total funding | $49.7M | $76.0M |
| Latest round | Series B2 | Series B |
| Valuation | $1.1B | Not published |
| LinkedIn followers | 4,364 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | ImmunoScape | LTZ Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 58/100 | 49/100 |
| Traction | 38/100 | 39/100 |
| Team | 70/100 | Not published |
| Search visibility | 23/100 | 17/100 |
| Quality | 68/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | D (50/100) |
| Domain ratingLink authority, 0-100 | 28/100 | 4/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | ImmunoScape | LTZ Therapeutics |
|---|---|---|
| Hosting | Not detected | AWS |
| CDN | Cloudflare | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Not detected |
| Analytics | Google Tag Manager | Not detected |
What users say
| Measure | ImmunoScape | LTZ Therapeutics |
|---|---|---|
| Reddit sentimentThreads we track | 6 positive, 0 negative across 6 threads | Not published |
“Singapore-based ImmunoScape Pioneers Next-Generation Cell Therapy for Solid Tumors; Announces Key Licensing Deal, New Board and SAB Appointments.”r/Quantisnow
ImmunoScape vs LTZ Therapeutics: common questions
Which is better, ImmunoScape or LTZ Therapeutics?
On our 0-100 score ImmunoScape rates higher (58/100 against 49/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do ImmunoScape and LTZ Therapeutics compare on the numbers?
ImmunoScape leads on our overall score (58/100 against 49/100), domain rating (28/100 against 4/100). LTZ Therapeutics leads on agent readiness (50/100 against 39/100), funding raised ($76.0M against $49.7M).
What do real users say about ImmunoScape and LTZ Therapeutics?
ImmunoScape: 6 positive and 0 negative mentions across 6 Reddit threads we track, mostly in r/Quantisnow.
Read the full ImmunoScape review and pricing or the LTZ Therapeutics review and pricing. You can also browse other ImmunoScape alternatives we track.